HomePharma & Biotech

Pharma & Biotech

Bayer Rides a Supreme Court Win to a 54% Rally, But a $7.25 Billion Decision Looms

Chemicals July 4, 2026

Sellas Life Sciences: A Single Hazard Ratio Holds the Key to a 950% Rally

Analysis July 3, 2026

Ocugen’s Summer of Data: Short Sellers Stand at 26% as Gene Therapy Milestones Converge

Analysis July 2, 2026

BioNTech’s Balancing Act: A Founder Exodus Meets a Make-or-Break Oncology Pipeline

Analysis July 1, 2026

Novo Nordisk’s Medicare Opening and Hemophilia Data Readout Set Up a Defining Summer

European Markets July 1, 2026

Ocugen Faces a Pivotal 90 Days as Retinitis Pigmentosa and Stargardt Data Converge

Analysis July 1, 2026

Sellas Life Sciences: The Stock That Surged 662% Now Faces Its Biggest Test — and a Potential Buyer

Mergers & Acquisitions June 30, 2026

Novo Nordisk’s Twin Catalysts: Medicare Bridge and UK Oral Wegovy Launch in Rapid Succession

European Markets June 30, 2026

1...181920...106 Page 19 of 106